Finanzwire Finanzwire
Basculer en Français
10429 Companies
218409 Keywords
147910 Articles
115543 Press releases
Headlines Articles Press releases Kootenay Resources Inc. Remove
  1. Home
  2. Companies
  3. Kootenay Resources Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/01/2025 at 14:05, 1 year ago

    Kootenay Resources Analyzes Promising Drill Results at Two Times Fred Property

    British Columbia Drill Results Epithermal Veins Gold Discovery Kootenay Resources
  • PRESS RELEASE

    published on 05/01/2025 at 14:00, 1 year ago

    CORRECTION FROM SOURCE: KTRI Reports on Drill Results From the Two Times Fred Property

    Kootenay Resources Inc. reports on drill assays revealing promising results from the Two Times Fred project in British Columbia, indicating potential for significant gold discovery and multiple mineralized veins
    British Columbia Gold Discovery Kootenay Resources Inc. Drill Assays Mineralized Veins
    Logo of Kootenay Resources Inc.
Accesswire
  • Published on 05/20/2026 at 00:00, 1 hour 5 minutes ago

    Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program

  • Published on 05/19/2026 at 19:45, 5 hours 20 minutes ago

    Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative

  • Published on 05/19/2026 at 16:47, 8 hours 18 minutes ago

    Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order

  • Published on 05/19/2026 at 15:15, 9 hours 50 minutes ago

    Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion

  • Published on 05/19/2026 at 15:00, 10 hours 5 minutes ago

    Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer

View all ACCESSWIRE
EQS Group
  • Published on 05/19/2026 at 21:24, 3 hours 40 minutes ago

    EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards

  • Published on 05/19/2026 at 19:50, 5 hours 14 minutes ago

    EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued

  • Published on 05/19/2026 at 19:40, 5 hours 24 minutes ago

    PRC-Saltillo Named to Forbes Accessibility 200 List

  • Published on 05/19/2026 at 19:05, 5 hours 59 minutes ago

    Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics

  • Published on 05/19/2026 at 18:56, 6 hours 8 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS
Les Echos
  • Published on 05/19/2026 at 18:45, 6 hours 20 minutes ago

    Closing of the sale of Novacel

  • Published on 05/19/2026 at 18:34, 6 hours 30 minutes ago

    Availability of preparatory documents for the annual general meeting to be held on June 9, 2026

  • Published on 05/19/2026 at 17:45, 7 hours 20 minutes ago

    EURAZEO INVESTS IN NEXTRON SYSTEMS, A GERMAN CYBERSECURITY COMPANY SPECIALISED IN THREAT INTELLIGENCE AND CYBER FORENSICS

  • Published on 05/18/2026 at 22:25, 1 day 2 hours ago

    Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares

  • Published on 05/18/2026 at 18:00, 1 day 7 hours ago

    Covivio Hotels - Covivio continues its expansion in hospitality in Southern Europe with a new acquisition in Torremolinos, Spain

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy